Synta Announces Positive One-Year Follow-up Results for the GALAXY-1 Trial of Ganetespib in NSCLC at the 2013 World Conference on Lung Cancer

28-10-2013 Business Wire HealthComments (0)

ganetespibPharmaceuticalSynta Pharmaceuticals

Synta Announces Positive One-Year Follow-up Results for GALAXY-1 Trial of Ganetespib in NSCLC at the 2013 WCLC Meeting

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top